You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-retroviral naive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

Not yet recruiting
  • HIV-1
  • +3 more
  • (no location specified)
Jan 17, 2023

HIV-1 Infection Trial in Berlin, Bucharest (MK-8558)

Completed
Has Results
  • HIV-1 Infection
  • Berlin, Germany
  • +1 more
May 5, 2021

Human Immunodeficiency Virus Trial (MK-8527)

Not yet recruiting
  • Human Immunodeficiency Virus
  • (no location specified)
Aug 8, 2022

Substance Abuse Among Anti-retroviral Treatment Naive Patients

Completed
  • HIV Infections
  • Substance like alcohol, marijuana, etc.
  • Khagaria, Bihar, India
    ART centre, Sadar Hospital
Mar 16, 2022

Early Anti-Retroviral Treatment in HIV- Infected Children

Active, not recruiting
  • HIV Infections
  • Blood samples collection
  • Bamako, Mali
  • +5 more
Mar 13, 2023

HIV Trial in San Diego (Digital Health Feedback System)

Active, not recruiting
  • HIV
  • Digital Health Feedback System
  • San Diego, California
  • +1 more
Dec 21, 2022

Hiv Trial

Not yet recruiting
  • Hiv
    • (no location specified)
    Apr 19, 2023

    HIV, Inpatient Facility Diagnoses Trial (Team Based Inpatient ARTAS, Standard of Care)

    Not yet recruiting
    • HIV Infections
    • Inpatient Facility Diagnoses
    • Team Based Inpatient ARTAS
    • Standard of Care
    • (no location specified)
    May 18, 2023

    Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria
    • Anti-C5 antibody treatment
    • Paris, France
      AP-HP Hôpital Saint Louis
    Apr 24, 2023

    Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept

    Not yet recruiting
    • Diabetic Macular Edema
    • +2 more
    • Vitrectomy combined with ILM peeling
    • Conbercept intravitreal injection
    • Tianjin, Tianjin, China
      Tianjin medical university eye hosipital
    Feb 14, 2023

    Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

    Recruiting
    • Severe Aplastic Anemia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Human Immunodeficiency Virus Trial in Pietermaritzburg (START Together)

    Active, not recruiting
    • Human Immunodeficiency Virus
    • START Together
    • Pietermaritzburg, KwaZulu-Natal, South Africa
      Human Sciences Research Council
    Nov 9, 2022

    HIV-1-infection Trial in Kisumu, Nairobi (Switch to B/F/TAF, Continue current regimen)

    Active, not recruiting
    • HIV-1-infection
    • Switch to B/F/TAF
    • Continue current regimen
    • Kisumu, Kenya
    • +1 more
    May 24, 2022

    HIV-1 Infection Trial in Berlin (MK-8583)

    Completed
    Has Results
    • HIV-1 Infection
    • Berlin, Germany
      Charite Research Organisation GmbH ( Site 0001)
    Feb 14, 2020

    HIV-1-infection, HIV Seropositivity Trial in Gent (Leucapheresis)

    Not yet recruiting
    • HIV-1-infection
    • HIV Seropositivity
    • Leucapheresis
    • Gent, Oost-Vlaanderen, Belgium
      UZ Gent
    Jul 25, 2023

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

    Active, not recruiting
    • Malignant Neoplasm
    • aldesleukin
    • +7 more
    • Los Angeles, California
      University of California at Los Angeles (UCLA )
    Dec 1, 2022

    HIV-1 Infection Trial in Berlin (MK-4250)

    Completed
    Has Results
    • HIV-1 Infection
    • Berlin, Germany
      Charite Research Organisation GmbH ( Site 0001)
    Oct 7, 2019

    Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

    Not yet recruiting
    • Lung Adenocarcinoma
    • +3 more
    • Serplulimab and Bevacizumab injection
    • (no location specified)
    Dec 21, 2022

    HIV/AIDS Trial in Atlanta (Genvoya)

    Completed
    Has Results
    • HIV/AIDS
    • Atlanta, Georgia
      Hope Clinic
    Jul 20, 2021

    Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

    Completed
    • Chronic Hepatitis B
    • NCO-48 Fumarate 4 mg
    • +2 more
    • Monterey Park, California
      National Institute of Clinical Research, Inc
    Jan 3, 2023

    Accurate Staging of Immuno-virological Dynamics During Acute HIV

    Recruiting
    • HIV
    • Seroconversion, HIV
    • Early combination anti-retroviral treatment
    • Gent, Oost-Vlaanderen, Belgium
      UZ Gent
    Oct 27, 2021

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

    Completed
    Has Results
    • Castration-Resistant Prostate Carcinoma
    • +5 more
    • Durvalumab
    • Tremelimumab
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 9, 2022

    HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection Trial in Marseille (CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN

    Terminated
    • HBe Negative Chronic Hepatitis B
    • Hepatitis B Viral Infection
    • CLEVUDINE + TENOFOVIR PLACEBO
    • +2 more
    • Marseille, France
      Hôpital Saint Joseph
    Jan 30, 2023